Beckman Coulter Exhibits New Hematology Analyzer in Middle East

MedLab Middle East 2019 took place at the Dubai International Convention and Exhibition Centre, Dubai, UAE, from February 4-7, 2019.

At the event, Beckman Coulter displayed its DxH 900 hematology analyzer, which allows mid- to high-volume clinical laboratories to perform complete blood count and white blood cell differential tests with minimal repeats. The DxH 900 analyzer offers advanced technologies to support patient care, by delivering the right results the first time. Foundational to the system are its core technologies, including the enhanced Coulter Principle, VCS 360 and DataFusion. These features offer high-resolution analysis of cells in their near-native states, providing a precise cellular assessment for excellent red blood cell, platelet and white blood cell test results on the first pass.

The DxH 900 analyzer demonstrates industry-leading 93% first-pass throughput, providing accurate flagging and reducing the number of slide reviews. This helps to generate reportable results as quickly as possible, reducing the time, supplies and costs that may be required for systems with higher repeat rates. Adding to this is the analyzer's lean reagent portfolio, which includes four reagents compared to 11 reagents required by other analyzers. Further, the DxH 900 features one of the smallest footprints in its class, making it highly efficient in utilization of laboratory space.